Related Experiment Video

Updated: May 8, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

FADD the bad in head and neck cancer

Paul Dent1

  • 1Department of Neurosurgery; Massey Cancer Center; Virginia Commonwealth University; Richmond, VA USA.

Cancer Biology & Therapy
|August 27, 2013
PubMed

Insights

Fas-associated death domain (FADD) protein is crucial in apoptosis and cell signaling. High FADD expression in head and neck cancer correlates with increased lymph node metastasis and reduced survival rates.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • Fas-associated death domain (FADD) is a key protein in the extrinsic apoptosis pathway.
  • FADD facilitates the activation of caspases by bridging death receptors and pro-caspases.
  • FADD also regulates NFκB and MAPK pathways, influencing cell proliferation and cycle progression.

Purpose of the Study:

  • To investigate the role and prognostic significance of FADD in head and neck cancer.
  • To examine the association between FADD expression and clinicopathological features, including lymph node metastasis and survival.

Main Methods:

  • Analysis of FADD expression in head and neck cancer tissues.
  • Correlation of FADD levels with lymph node metastasis and patient survival data.

Main Results:

  • High expression of FADD was observed in head and neck cancer.
  • Elevated FADD levels were significantly associated with increased lymph node metastasis.
  • Higher FADD expression correlated with shorter survival times in head and neck cancer patients.

Conclusions:

  • FADD plays a significant role in head and neck cancer progression.
  • FADD expression serves as a potential prognostic biomarker for lymph node metastasis and survival in head and neck cancer.
Keywords:
DR5FADDcaspase-8head and neck cancerimmunohistochemistrymetastasisprognosis

More Related Videos

Modified Radical Neck Dissection for Cervical Metastasis06:05

Modified Radical Neck Dissection for Cervical Metastasis

Published on: February 20, 2026

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

Related Concept Videos

Veins of Head and Neck01:19

Veins of Head and Neck

The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Arteries of the Head and Neck01:26

Arteries of the Head and Neck

The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...